MAPT and Alzheimer disease: The brain of Alzheimer’s disease (AD) patients is characterized by Amyloid β (Aβ) accumulation and hyperphosphorylation of tau protein, causing neuroinflammation and oxidative stress leading to neurodegeneration and cognitive impairment [135].